anmelden
FTSE All-Share
5.576,38
PKT
-20,66
PKT
-0,37
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.10.12 | Smith Nephew sell | Société Générale Group S.A. (SG) | |
| 10.10.12 | Rio Tinto outperform | RBC Capital Markets | |
| 10.10.12 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 09.10.12 | Rio Tinto buy | UBS AG | |
| 09.10.12 | BP neutral | Exane-BNP Paribas SA | |
| 09.10.12 | Rio Tinto outperform | Credit Suisse Group | |
| 09.10.12 | PageGroup underperform | Exane-BNP Paribas SA | |
| 09.10.12 | Abrdn outperform | Exane-BNP Paribas SA | |
| 09.10.12 | Prudential underperform | Exane-BNP Paribas SA | |
| 09.10.12 | Legal General underperform | Exane-BNP Paribas SA | |
| 09.10.12 | BP overweight | J.P. Morgan Cazenove | |
| 12.10.12 | Rio Tinto outperform | RBC Capital Markets | |
| 09.10.12 | Hays hold | ING | |
| 08.10.12 | Sky buy | Nomura | |
| 08.10.12 | Abrdn overweight | J.P. Morgan Cazenove | |
| 08.10.12 | Imperial Brands reduce | Nomura | |
| 08.10.12 | BAT buy | Nomura | |
| 08.10.12 | Anglo American neutral | UBS AG | |
| 08.10.12 | Anglo American neutral | Sarasin Research | |
| 08.10.12 | Shell (ex Royal Dutch Shell) outperform | Exane-BNP Paribas SA | |
| 08.10.12 | BP neutral | Exane-BNP Paribas SA | |
| 05.10.12 | GSK neutral | Credit Suisse Group | |
| 05.10.12 | Burberry neutral | UBS AG | |
| 05.10.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 05.10.12 | BP halten | Independent Research GmbH | |
| 05.10.12 | Diageo buy | Nomura | |
| 05.10.12 | Whitbread buy | Nomura | |
| 05.10.12 | 3i hold | Société Générale Group S.A. (SG) | |
| 04.10.12 | BP overweight | J.P. Morgan Cazenove | |
| 04.10.12 | Shell (ex Royal Dutch Shell) neutral | J.P. Morgan Cazenove | |
| 04.10.12 | Vodafone Group overweight | J.P. Morgan Cazenove | |
| 04.10.12 | J. Sainsbury underperform | Exane-BNP Paribas SA | |
| 04.10.12 | AstraZeneca reduce | Nomura | |
| 04.10.12 | FirstGroup equal-weight | Morgan Stanley | |
| 04.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
| 04.10.12 | Pearson outperform | Exane-BNP Paribas SA | |
| 04.10.12 | FirstGroup neutral | UBS AG | |
| 03.10.12 | Rio Tinto buy | Deutsche Bank AG | |
| 03.10.12 | Unilever hold | ING | |
| 03.10.12 | AstraZeneca underperform | Credit Suisse Group |